VIPR1-AS1

Across TCGA pan-cancer cohorts, VIPR1-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated VIPR1-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher VIPR1-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated VIPR1-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

BLCA, ACC, and HNSC are the cancer types where VIPR1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	II,III,IV	0.779	0.618	.002	50	view →
ACC	DFS	Median	II,III,IV	0.461	0.736	.007	50	view →
HNSC	OS	Tertile	II,III,IV	0.528	0.251	.001	44	view →
LIHC	OS	Quartile	All	0.871	0.564	.001	36	view →
KICH	OS	Median	III,IV	0.309	0.906	.003	25	view →
DLBC	DFS	Median	All	0.590	1.000	.005	21	view →
LUAD	OS	Quartile	All	0.822	0.623	.003	20	view →
KIRP	OS	Tertile	II,III,IV	0.745	0.149	.019	20	view →
READ	OS	Tertile	III,IV	0.849	0.315	.003	19	view →
PCPG	OS	Median	All	0.921	1.000	.004	17	view →
BRCA	OS	Tertile	II,III,IV	0.970	0.939	.021	16	view →
UCEC	OS	Median	All	0.910	0.941	.033	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

VIPR1-AS1–BLCA (OS)

Open the BLCA breakdown →